DE602004017164D1 - Albuminkonjugate, die eine Glucuron-Verknüpfung enthalten - Google Patents

Albuminkonjugate, die eine Glucuron-Verknüpfung enthalten

Info

Publication number
DE602004017164D1
DE602004017164D1 DE602004017164T DE602004017164T DE602004017164D1 DE 602004017164 D1 DE602004017164 D1 DE 602004017164D1 DE 602004017164 T DE602004017164 T DE 602004017164T DE 602004017164 T DE602004017164 T DE 602004017164T DE 602004017164 D1 DE602004017164 D1 DE 602004017164D1
Authority
DE
Germany
Prior art keywords
glucuron
linkage
conjugates containing
albumin conjugates
albumin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602004017164T
Other languages
English (en)
Inventor
Eva Frei
Hans-Hermann Schrenk
Christoph Fiehn
Paul Kremer
Andrea Breuer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Deutsches Krebsforschungszentrum DKFZ
Universitaet Heidelberg
Original Assignee
Deutsches Krebsforschungszentrum DKFZ
Universitaet Heidelberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforschungszentrum DKFZ, Universitaet Heidelberg filed Critical Deutsches Krebsforschungszentrum DKFZ
Publication of DE602004017164D1 publication Critical patent/DE602004017164D1/de
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE602004017164T 2004-08-09 2004-08-09 Albuminkonjugate, die eine Glucuron-Verknüpfung enthalten Expired - Fee Related DE602004017164D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04018855A EP1625854B1 (de) 2004-08-09 2004-08-09 Albuminkonjugate, die eine Glucuron-Verknüpfung enthalten

Publications (1)

Publication Number Publication Date
DE602004017164D1 true DE602004017164D1 (de) 2008-11-27

Family

ID=34926104

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004017164T Expired - Fee Related DE602004017164D1 (de) 2004-08-09 2004-08-09 Albuminkonjugate, die eine Glucuron-Verknüpfung enthalten

Country Status (4)

Country Link
EP (1) EP1625854B1 (de)
AT (1) ATE411053T1 (de)
DE (1) DE602004017164D1 (de)
ES (1) ES2315600T3 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2111857A1 (de) 2008-04-25 2009-10-28 Acino AG Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff hiervon
EP2295046B1 (de) 2009-09-14 2012-12-19 Acino AG Transdermales therapeutisches System zur Verabreichung von Fentanyl oder einem Analogstoff davon
WO2011146638A1 (en) * 2010-05-18 2011-11-24 Cerulean Pharma Inc. Compositions and methods for treatment of autoimmune and other diseases
CN106310290B (zh) * 2016-10-27 2019-08-23 深圳先进技术研究院 一种肿瘤靶向性热敏前药及其制备方法与应用
JP7330101B2 (ja) 2016-11-08 2023-08-21 レゲネロン ファーマシューティカルス，インコーポレーテッド ステロイド及びそのタンパク質コンジュゲート
AU2018270784B2 (en) 2017-05-18 2024-05-16 Regeneron Pharmaceuticals, Inc. Cyclodextrin protein drug conjugates
KR20210008008A (ko) 2018-05-09 2021-01-20 리제너론 파마슈티칼스 인코포레이티드 항-msr1 항체 및 이의 사용 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5828664A (ja) * 1981-08-13 1983-02-19 Eiken Kagaku Kk エストラジオ−ル−１７β−グルクロナイド測定用抗原およびその製造法
JPS5833162A (ja) * 1981-08-21 1983-02-26 Eiken Kagaku Kk エストリオ−ル−１６α−グルクロナイド測定用抗原およびその製造法
JPS6061596A (ja) * 1983-09-16 1985-04-09 Eiken Kagaku Kk 新規ステロイド化合物，その製造方法，及びその化合物からなる免疫化学的測定法によるエストラジオ−ル−３−サルフエ−ト−１７β−グルクロナイド測定用抗原
IT8922275A0 (it) * 1990-10-25 1989-11-06 Baldacci Lab Spa Nuovi derivati di corticosteroidi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
WO1993022334A1 (en) * 1992-05-04 1993-11-11 Sri International Pharmaceutical compositions and methods for colonic delivery of corticosteroids
CA2152374A1 (en) * 1993-01-08 1994-07-21 Ralph Lennart Brattsand Novel colon- or ileum-specific steroid derivatives
WO1995009177A1 (fr) * 1993-09-29 1995-04-06 Nissin Shokuhin Kabushiki Kaisha Compose steroide substitue en position 21

Also Published As

Publication number Publication date
ATE411053T1 (de) 2008-10-15
EP1625854B1 (de) 2008-10-15
ES2315600T3 (es) 2009-04-01
EP1625854A1 (de) 2006-02-15

Similar Documents

Publication Publication Date Title
LTC1620113I2 (lt) Ivermektino topinė kompozicija, skirta dermatologinių susirgimų gydymui
LTPA2016034I1 (lt) Brutono tirozinkinazės inhibitoriai
DK1487416T3 (da) Lægemiddelmikropartikler
NO20075660L (no) Blanding for behandling av inflammatoriske sykdommer
CY1108514T1 (el) Παραγωγα 1-φαινυλαλκανεκαρβοξυλικου οξεος για τη θεραπεια νευρογενων ασθενειων
CY1110606T1 (el) Χρηση των ανταγωνιστων της il-23 και il-17 για τη θεραπεια της αυτοανοσης οφθαλμικης φλεγμονωδους νοσου
WO2003096989A3 (en) Anti tubercular drug: compositions and methods
DE60325379D1 (de) Zusammensetzung enthaltend 6-Ä3-(1-adamantyl)-4-methoxyphenylÜ-2-naphthanoesäure zur Behandlung dermatologischer Erkrankungen
CY1108932T1 (el) Ενωσεις 4-(ετεροκυκλυλ)-βενζολοσουλφοξιμινης για την θεραπευτικη αγωγη φλεγμονωδων ασθενειων
DE60126923D1 (de) Therapeutische zusammensetzungen bestehend aus antihypotensiva und antiangiogenika
ITMI20041317A1 (it) Formulazioni farmaceutiche per la somministrazione sicura di farmaci utilizzati nel trattamento della tossicodipendenza e procedimento per il loro ottenimento
AR026610A1 (es) Un derivado pirrolidinacetamida solo o en combinacion para tratamiento de desordenes del sistema nervioso central
ATE429416T1 (de) Cyanophenoxy-carbonsäuren und zusammensetzungen für die freisetzung aktiver substanzen
BRPI0413427A (pt) derivados de piridilpirrol ativos como inibidores da cinase
AR048342A1 (es) FORMAS DE DOSIFICACIoN FARMACÉUTICAS QUE COMPRENDEN EL ÁCIDO N-(2-(2-FTALIMIDOETOXI)-ACETIL)-L-ALANIL-D-GLUTÁMICO (LK-423)
NO20071798L (no) Dermalt pafore formuleringer for behandling av hudsykdommer i dyr
WO2003026563A3 (en) Conjugated anti-psychotic drugs and uses thereof
DE602004017164D1 (de) Albuminkonjugate, die eine Glucuron-Verknüpfung enthalten
NO20051159L (no) Preparater og fremgangsmater for behandling av sykdommer som viser feilsammensetting av aggregering av protein
ITRM20040223A1 (it) Medicamento per il trattamento delle infezioni fungine, in particolare dell'aspergillosi.
NO20031650D0 (no) Nye legemidler for leversykdommer
WO2021262910A3 (en) Tubulysins and protein-tubulysin conjugates
ITMI20020872A1 (it) Derivati dell'iperforina loro uso e formulazioni che li contengono
ATE545421T1 (de) Pharmazeutisches präparat zur behandlung von parasitären tropenkrankheiten enthaltend diminazen-di-aceturat
RU2003136675A (ru) Способ повышения сохранности молодняка крупного рогатого скота

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee